GSK5533524
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2026
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=97 | Not yet recruiting | Sponsor: GlaxoSmithKline
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1